Arcutis Biotherapeutics Stock Forward View - Accumulation Distribution
| ARQT Stock | USD 26.71 0.12 0.45% |
Arcutis Stock outlook is based on your current time horizon.
At this time the rsi of Arcutis Biotherapeutics' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (0.14) | EPS Estimate Next Year 0.4571 | Wall Street Target Price 31.75 | EPS Estimate Current Quarter (0.10) |
Using Arcutis Biotherapeutics hype-based prediction, you can estimate the value of Arcutis Biotherapeutics from the perspective of Arcutis Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Arcutis Biotherapeutics using Arcutis Biotherapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Arcutis using crowd psychology based on the activity and movement of Arcutis Biotherapeutics' stock price.
Arcutis Biotherapeutics Short Interest
An investor who is long Arcutis Biotherapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Arcutis Biotherapeutics and may potentially protect profits, hedge Arcutis Biotherapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 20.0253 | Short Percent 0.1606 | Short Ratio 10.6 | Shares Short Prior Month 15.2 M | 50 Day MA 28.0844 |
Arcutis Relative Strength Index
Arcutis Biotherapeutics Hype to Price Pattern
Investor biases related to Arcutis Biotherapeutics' public news can be used to forecast risks associated with an investment in Arcutis. The trend in average sentiment can be used to explain how an investor holding Arcutis can time the market purely based on public headlines and social activities around Arcutis Biotherapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Arcutis Biotherapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Arcutis Biotherapeutics.
Arcutis Biotherapeutics Implied Volatility | 1.66 |
Arcutis Biotherapeutics' implied volatility exposes the market's sentiment of Arcutis Biotherapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Arcutis Biotherapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Arcutis Biotherapeutics stock will not fluctuate a lot when Arcutis Biotherapeutics' options are near their expiration.
Arcutis Biotherapeutics after-hype prediction price | USD 26.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Arcutis Biotherapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Arcutis contract
Based on the Rule 16, the options market is currently suggesting that Arcutis Biotherapeutics will have an average daily up or down price movement of about 0.1% per day over the life of the 2026-03-20 option contract. With Arcutis Biotherapeutics trading at USD 26.71, that is roughly USD 0.0277 . If you think that the market is fully incorporating Arcutis Biotherapeutics' daily price movement you should consider acquiring Arcutis Biotherapeutics options at the current volatility level of 1.66%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Arcutis Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Arcutis Biotherapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Arcutis Biotherapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Arcutis Biotherapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Arcutis Biotherapeutics' open interest, investors have to compare it to Arcutis Biotherapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Arcutis Biotherapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Arcutis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Arcutis Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Arcutis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arcutis using various technical indicators. When you analyze Arcutis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 33287.41 | 35761.26 |
| Check Arcutis Biotherapeutics Volatility | Backtest Arcutis Biotherapeutics | Information Ratio |
Arcutis Biotherapeutics Trading Date Momentum
| On February 12 2026 Arcutis Biotherapeutics was traded for 26.71 at the closing time. The top price for the day was 26.76 and the lowest listed price was 25.89 . The trading volume for the day was 1.1 M. The trading history from February 12, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.11% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Arcutis Biotherapeutics to competition |
Other Forecasting Options for Arcutis Biotherapeutics
For every potential investor in Arcutis, whether a beginner or expert, Arcutis Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Arcutis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Arcutis. Basic forecasting techniques help filter out the noise by identifying Arcutis Biotherapeutics' price trends.Arcutis Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arcutis Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Arcutis Biotherapeutics could also be used in its relative valuation, which is a method of valuing Arcutis Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Arcutis Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Arcutis Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcutis Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Arcutis Biotherapeutics stock market strength indicators, traders can identify Arcutis Biotherapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 35761.26 | |||
| Daily Balance Of Power | 0.1379 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 26.33 | |||
| Day Typical Price | 26.45 | |||
| Price Action Indicator | 0.45 | |||
| Period Momentum Indicator | 0.12 |
Arcutis Biotherapeutics Risk Indicators
The analysis of Arcutis Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Arcutis Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arcutis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.11 | |||
| Semi Deviation | 2.02 | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.14 | |||
| Downside Variance | 5.01 | |||
| Semi Variance | 4.07 | |||
| Expected Short fall | (2.57) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Arcutis Biotherapeutics
The number of cover stories for Arcutis Biotherapeutics depends on current market conditions and Arcutis Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arcutis Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arcutis Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Arcutis Biotherapeutics Short Properties
Arcutis Biotherapeutics' future price predictability will typically decrease when Arcutis Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Arcutis Biotherapeutics often depends not only on the future outlook of the potential Arcutis Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcutis Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 121 M | |
| Cash And Short Term Investments | 228 M |
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.